Juno Therapeutics Reports Fourth Quarter and 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Juno Therapeutics (JUNO) Posts Q4 Loss of $1.61/Share
March 18, 2015 4:03 PM EDTJuno Therapeutics (NASDAQ: JUNO) reported Q4 EPS of ($1.61), $1.28 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Juno Therapeutics (JUNO) click here.
... More